Transfusion Medicine (Comprehensive, Limited) J, J1

Similar documents
Histocompatibility. HLA Serologic Typing (Class I/II) ABO, HLAS, HLAS Surveys & Anatomic Pathology Education Programs

DAT-B 2015 Direct Antiglobulin Test

Laboratory Results Summary

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

REFERENCE LABORATORY. Regular Hours - Monday through Friday 8:00 AM to 4:00 PM. On-Call Staff - Evenings, Nights, Weekend and Holidays.

Screening donors and donations for transfusion transmissible infectious agents. Alan Kitchen

2008 CAP TODAY Q & A

The testing of Donated Blood and Components at NHSBT

Answering your daily challenges. in the ELISA technology I N FECTI OUS DISEASES. bioelisa

Blood Component Testing and Labeling

Perform Gram stain only. Select Survey D5, Gram Stain

Direct Antiglobulin Test (DAT)

QUALITY CONTROL Infectious Disease

DIAGNOSTIC SERVICES MANITOBA

Laboratory Diagnosis of Viral Infections. G. Jamjoom 2005

HEPATITIS B NON-IMMEDIATE NOTIFICATION EPIDEMIOLOGY PROGRAM

TRANSFUSION ASSOCIATED DISEASE, RECALL, OR COMPLICATION INVESTIGATION POLICY I. FATALITIES AND COMPLICATIONS ASSOCIATED WITH TRANSFUSION:

CASE STUDIES IN CLINICAL APPLICATIONS OF THERAPEUTIC PLASMA EXCHANGE

Non-reproductive tissues and cells Recommending authority/ association

Viral Hepatitis Diagnosis and Management

Table of Contents (continued)

Non-reproductive tissues and cells

Transfusion Reactions. Directed by M-azad March 2012

OHIOHEALTH Laboratory Services INPATIENT, ED AND OTHER HOSPITAL BASED PATIENT CRITICAL VALUE NOTIFICATION LIST

Controls & Calibrators. Disease Quality Controls

Diagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)

The Alphabet Soup of Viral Hepatitis Testing

A written order to request the performance of a laboratory test can be initiated by the following parties:

PILOT STUDY OF ANTIGEN MATCHING FOR AUTOIMMUNE HEMOLYTIC ANEMIA

APPROACH TO RISK MANAGEMENT IN MEDICAL PRACTICE: STANDPOINT OF THE BLOOD TRASFUSION*

Duration: 12 months May to April

CLIA APPROVED PROFICIENCY TESTING PROGRAMS ACCUTEST, INC. P.O. Box 999 Westford, Massachusetts (800)

The Technical Aspects of Pathogen Testing in Canada. Nancy Angus Canadian Blood Services Director, Testing

Blood transfusion. Dr. J. Potgieter Dept. of Haematology NHLS - TAD

Non-reproductive tissues and cells

Structure and duties of Blood service

to be notified: all parties involved in the graduated plan procedure. Annexes

Khalid Alquthami (Correspondence) Regional Lab, Makkah. Saudi Arabia

Guidance for Industry

Non-reproductive tissues and cells

Test Critical Low Critical High Alerting Category

JOB AID CRITICAL VALUES AND TESTS W/O MICRO CRITICAL TESTS. Always call results for the following test(s):

For more information about how to cite these materials visit

Cord Blood Bankers are. Angie Yost, MT(ASCP) CM 2016 ASCLS-MO CLMA Spring Meeting

EC CERTIFICATE. National Institute for Biological Standards and Control (NIBSC) Blanche Lane South Mimms Potters Bar Hertfordshire EN6 3QG UK

Public Health, Infections and Transplantation

Reporting from Council of Europe member states on the collection, testing and use of blood and blood components in Europe The 2006 Survey

Blood Product Modifications: Leukofiltration, Irradiation and Washing

CORD BLOOD TRANSPLANTATION STUDY CBU EXCLUSION AND QUARANTINE RELEASE FORM

Hepatitis A virus (HAV)

HIV Testing Technology and the Latest Algorithm

Reflex Test Protocols

Non-reproductive tissues and cells

Laboratory Values, Critical. ThedaCare. Date Last Reviewed: 4/5/2018 Reviewing Body(s): Quality; Laboratory Leadership

VM-A 2011 Viral Markers

Brrrr, It s Cold In Here

Within 14 days at 2-8⁰C. DO NOT FREEZE WHOLE BLOOD Micro Typing Systems 50 µl plasma

NLBCP-017 INDIRECT ANTIGLOBULIN CROSSMATCH TUBE METHOD. Issuing Authority

Mary Berg, M.D. Medical Director, Transfusion Services Associate Professor of Pathology University of Colorado Hospital

PROFICIENCY TESTING. Clinical Laboratory Improvement Amendments (CLIA) DOs and DON Ts. Brochure # 8

Non-reproductive tissues and cells Recommending authority/ association

We are pleased to present the new Leaflet bioelisa Menu and Instrumentation, with reference

WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: OraQuick HCV Rapid Antibody Test Kit WHO reference number: PQDx

Step-by-Step Instructions For OraQuick HCV Rapid Antibody Test

Cryopreserved Human Hepatocytes (Cat # HP-F)

Hepatitis C Best Practice Guidelines For Local Health Departments

INVESTIGATION OF ADVERSE TRANSFUSION REACTIONS NLBCP-006. Issuing Authority

Center for Biologics Evaluation and Research

Transfusion therapy: what is new with respect to safety and control of iron loading? Yesim AYDINOK

Private Patients Pricelist

CORD BLOOD TESTING AND HDFN A CASE STUDY. Eric Rosa, MLS (ASCP) CM University of Kansas Hospital April 20, 2016

Risks and Benefits of Blood Transfusions. Objectives. Red Cells (Erythrocytes) Understand the following:

Viral hepatitis. Supervised by: Dr.Gaith. presented by: Shaima a & Anas & Ala a

Official Journal of the European Communities COMMISSION

Non-reproductive tissues and cells

10/18/2012. A primer in HLA: The who, what, how and why. What?

A Transfusion Reaction What Do I Do Now? Judith A. Sullivan, MS, MT(ASCP)SBB, CQA(ASQ) ASCLS Region III Triennial Meeting Birmingham AL

Test Name Results Units Bio. Ref. Interval

8/28/2018. Disclosures. Objectives. None. Automation to PreciseType and Everything in Between

Automation to PreciseType and Everything in Between. Jessie Singer MT(ASCP) Transfusion Medicine Children s Hospital Los Angeles

Blood Components & Indications for Transfusion. Neda Kalhor

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes

Test Name Results Units Bio. Ref. Interval

Investigation of Transfusion Complications

DIAGNOSTIC AUTOMATION, INC.

Blood Screening Assays. CTS lab locations where assays are performed are indicated by alpha codes D, P, and T.

TRANSFUSION REACTION EVALUATION

2014/LSIF/PD/025 Malaysia s Approach to Testing Strategies

Blood Transfusion. What is blood transfusion? What are blood banks? When is a blood transfusion needed? Who can donate blood?

INSTRUCTIONS FOR BLOOD BANK INSPECTION CHECKLIST AND REPORT CMS-282

1. The minimum hemoglobin concentration in a fingerstick from a male donor is: a g/dl (120g/L) b. 12.5g/dL (125g/L) c. 13.5g/dL (135g/L) d.

ACMG/CAP Cytogenetics CY

Understanding Transfusion Medicine

Reflex Test Protocols

Test Name Results Units Bio. Ref. Interval

Simulated ABO & Rh Bood Typing Lab Activity Student Study Guide

TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES ADVISORY COMMITTEE MEETING October2010. Issue Summary

AccuSet HBV Worldwide Performance Panel

Transcription:

www.cap.org Transfusion Medicine Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). Transfusion Medicine (Comprehensive, Limited) J, J1 Procedure J J1 Challenges per Shipment ABO grouping 5 Rh typing 5 Antibody detection 5 Antibody identification 5 Compatibility testing 5 Red blood cell antigen detection 1 Category 1 CME CE Surveys J and J1 are designed for pretransfusion testing by manual techniques. See the Transfusion Medicine Automated Testing Survey (JAT) for automated instruments on page 156. For additional educational challenges to complement your proficiency testing, refer to Survey JE1 (see page 157). For competency assessment of technologists ability to perform comprehensive pretransfusion testing, please refer to Survey TMCA, Transfusion Medicine Competency Assessment Comprehensive Transfusion Medicine. Each shipment will include five 2.0-mL specimens of a 3% red blood cell suspension and five 3.0-mL corresponding serum specimens. Survey J shipments will also include one 2.0-mL donor red blood cell suspension. An education activity is planned that includes reading material found in the Participant Summary/Final Critique and online learning assessment questions. All laboratory staff can participate individually and earn free CME/CE credit without leaving the laboratory. 2008 Surveys & Anatomic Pathology Education Programs Transfusion Medicine 155

800-323-4040 Option 1 for Customer Contact Center New Cord Blood CBT Analyte CBT Challenges per Shipment Absolute CD34 2 Absolute CD3 2 Absolute CD45 2 Bacterial culture 2 % CD34+ 2 % CD45+ 2 CFU-GM 2 Fungal culture 2 Hematocrit 2 Hemoglobin 2 Mononuclear cell count 2 % CD3 2 Total nucleated cells 2 Total nucleated red cells 2 Viability 2 WBC count 2 Each shipment will include two specimens for the proficiency testing of assays required for the production of umbilical cord blood stem cell products. Transfusion Medicine Automated Testing JAT Procedure JAT Challenges per Shipment ABO grouping 5 Antibody detection 5 Rh typing 5 Antibody detection 5 Survey JAT is designed for automated blood banking instruments. For antibody identification and compatibility testing by manual techniques, refer to Survey J (see page 155). For additional educational challenges to complement your proficiency testing, refer to Survey JE1 (see page 157). For competency assessment of technologists ability to perform comprehensive pretransfusion testing, please refer to Survey TMCA, Transfusion Medicine Competency Assessment Comprehensive Transfusion Medicine. Each shipment will include five specimens. 156 Transfusion Medicine College of American Pathologists

www.cap.org Direct Antiglobulin Testing DAT Procedure DAT Challenges per Shipment Direct antiglobulin testing 3 Survey DAT is designed for laboratories performing direct antiglobulin testing as a stand-alone test or as part of any of the following work-ups: pretransfusion compatibility testing, transfusion reaction, autoimmune hemolytic anemia, and/or hemolytic disease of the newborn. Each shipment will include three 2.0-mL specimens of a 3-4% red blood cell suspension. For competency assessment of technologists ability to perform direct antiglobulin testing, please refer to Survey TMCAD, Transfusion Medicine Competency Assessment Direct Antiglobulin Test. Transfusion Medicine Educational Challenges JE1 Program JE1 Challenges per Shipment Educational challenge 1 Category 1 CME CE Survey JE1 provides maximum educational benefits for laboratories performing comprehensive Transfusion Medicine testing. A variety of Transfusion Medicine challenges comprise Survey JE1. These may include, but are not limited to, paper challenges, serum specimens for antibody detection and identification, red blood cell suspensions for ABO grouping, Rh typing, and direct antiglobulin testing, and/or 35mm slide challenges. An education activity is planned that includes reading material found in the Participant Summary/Final Critique and online learning assessment questions. All laboratory staff can participate individually and earn free CME/CE credit without leaving the laboratory. Product Fulfillment Group J 2008 Surveys & Anatomic Pathology Education Programs Transfusion Medicine 157

800-323-4040 Option 1 for Customer Contact Center Transfusion Medicine Competency Assessment Comprehensive Transfusion Medicine TMCA Procedure TMCA Challenges per Shipment ABO grouping 2 Antibody detection 2 Antibody identification 2 Compatibility testing 2 Rh typing 2 Note: Shipments may be ordered individually. Survey TMCA is designed for laboratory directors and managers to assess the competency of their technical staff in performing routine pretransfusion testing. Shipments may be ordered individually or for an entire year. Intended responses will be mailed to participants approximately four weeks after receipt, enabling laboratory managers or directors to perform an evaluation of technologist performance. Each shipment of Survey TMCA will contain two 2.0-mL specimens of a 3% red blood cell suspension and two 3.0-mL corresponding serum specimens, along with one donor 3.0-mL 3% red blood cell suspension. Transfusion Medicine Competency Assessment Direct Antiglobulin Test TMCAD Procedure TMCAD Challenges per Shipment Direct antiglobulin testing 2 Note: Shipments may be ordered individually. Survey TMCAD is designed for laboratory directors and managers to assess the competency of their technical staff in performing direct antiglobulin testing. Shipments may be ordered individually or for an entire year. Intended responses will be mailed to participants approximately four weeks after receipt, enabling laboratory managers or directors to perform an evaluation of technologist performance. Each shipment of Survey TMCAD will contain two 2.0-mL specimens of a 3-4% red blood cell suspension. 158 Transfusion Medicine College of American Pathologists

www.cap.org Fetal Red Cell Determination HBF Analyte/Procedure HBF Challenges per Shipment F cell value 2 Hemoglobin F, qualitative (fetal screen) 2 Hemoglobin F, quantitative 2 The F cell value is compatible with flow cytometry methods. Qualitative (screen) Hemoglobin F is compatible with E-rosette testing for D(Rh o ) fetal red blood cells in the maternal circulation. Quantitative Hemoglobin F is compatible with Kleihauer-Betke and flow cytometry methods. Each shipment will include two 1.2-mL liquid stabilized red blood cell specimens. For competency assessment of technologists ability to perform fetal red cell quantitation, please refer to Survey TMCAF, Transfusion Medicine Competency Assessment Fetal Red Cell Quantitation. Transfusion Medicine Competency Assessment Fetal Red Cell Quantitation TMCAF Procedure TMCAF Challenges per Shipment Kleihauer-Betke 2 Fetal Screen 2 Note: Shipments may be ordered individually. Survey TMCAF is designed for laboratory directors and managers to assess the competency of their technical staff in performing qualitative and/or quantitative tests for hemoglobin F. Compatible methods include: for qualitative hemoglobin F: E-rosette testing for D(Rh o ) fetal red blood cells in the maternal circulation; and for quantitative hemoglobin F: Kleihauer-Betke and flow cytometry methods. Shipments may be ordered individually or for an entire year. Intended responses will be mailed to participants approximately four to six weeks after kit receipt, enabling laboratory managers or directors to perform a self-evaluation of technologist performance. Each shipment of Survey TMCAF will contain two 1.2-mL specimens of stabilized red blood cell suspensions. 2008 Surveys & Anatomic Pathology Education Programs Transfusion Medicine 159

800-323-4040 Option 1 for Customer Contact Center Platelet Serology PS Procedure PS Challenges per Shipment Antibody detection 3 Platelet crossmatch 3 Survey PS participants will crossmatch each plasma specimen provided with ten units of platelets from their institution and report the percentage of units that are serologically incompatible. Participants will also report results of an antibody screen. Note: A low concentration of sodium azide may be present in the specimens and may affect lymphocytotoxicity methods. Each shipment will include three 3.0-mL plasma specimens. This material is compatible with solid-phase red cell adherence, flow cytometry, EIA/ELISA, and RIA methods. Stem Cell Processing SCP Procedure SCP Challenges per Shipment Absolute CD3 2 Absolute CD34 2 Bacterial culture 2 % CD34+ 2 % CD45 2 CFU-GM 2 Fungal culture 2 Hematocrit 2 Mononuclear cell count 2 % CD3 2 Total nucleated cells 2 Total nucleated red cells 2 Viability 2 WBC count 2 Survey SCP is designed for laboratories processing and handling stem cells. The Survey will assess each laboratory s ability to determine if a stem cell product is suitable for use based on the results of the above analytes. The Survey will contain two specimens of peripheral blood for laboratory analysis. 160 Transfusion Medicine College of American Pathologists

www.cap.org Viral Marker Chemistry VMC Analyte VMC Challenges per Shipment Alanine aminotransferase (ALT/SGPT) 5 Cholesterol 5 Protein, total 5 Survey VMC is designed for laboratories performing viral markers testing and alanine aminotransferase, cholesterol, or total protein testing. Each shipment will include five 5.0-mL liquid plasma specimens. Transfusion-Related Cell Count TRC Procedure TRC Challenges per Shipment Platelet count (Platelet-Rich Plasma) 5 WBC count (Leukocyte-Reduced Platelet Suspension) 2 WBC count (Leukocyte-Reduced Red Blood Cell Suspension) 2 Survey TRC provides Hematology and/or Transfusion Medicine laboratories with proficiency testing material for various cell count procedures. The Platelet-Rich Plasma material can be utilized for both manual and automated platelet count methods. The Leukocyte-Reduced Red Blood Cell suspensions and Leukocyte-Reduced Platelet suspensions provide laboratories with an opportunity to assess their ability to perform low white blood cell (WBC) counts. Note: The Leukocyte-Reduced Red Blood Cell and the Leukocyte-Reduced Platelet materials must be used with a Nageotte chamber or flow cytometry. Each shipment will include five 1.2-mL suspensions of stabilized mammalian Platelets (Platelet-Rich Plasma), two 1.0-mL vials containing a Leukocyte-Reduced Red Blood Cell material, and two 1.0-mL vials containing a Leukocyte-Reduced Platelet material. 2008 Surveys & Anatomic Pathology Education Programs Transfusion Medicine 161

800-323-4040 Option 1 for Customer Contact Center Eluate Survey ELU Procedure ELU Challenges per Shipment Antibody elution 2 Survey ELU is designed for laboratories performing antibody elutions (for non-abo antibodies) as a part of an antibody identification workup or direct antiglobulin test. Each shipment will include two 2.0-mL 50% red blood cell suspension specimens for use in performing antibody elutions. Antibody Titer ABT, ABT1, ABT2 Analyte/Procedure ABT ABT1 ABT2 Challenges per Shipment Anti-A Titer 1 Anti-D Titer 1 Survey ABT is designed for laboratories performing red cell antibody titers as a part of any of the following workups: a prenatal antibody quantification workup; the management of recipients of ABO incompatible bone marrow transplants; to determine eligibility of O or B kidney transplant recipient candidates for receiving an A 2 kidney; and/or to assess the need and monitor the effect of plasma exchange in transplant recipients who are ABO incompatible with their donors. Survey ABT1 is designed for laboratories performing titers for Anti-A. Survey ABT2 is designed for laboratories performing titers for Anti-D. Laboratories ordering Surveys ABT, ABT1, or ABT2 will be able to report using a variety of techniques. Each shipment of Survey ABT will include one plasma specimen for anti-d titer with one corresponding titer cell (3% red blood cell suspension) and one plasma specimen for anti-a titer with one corresponding titer cell (3% red blood cell suspension). Each shipment of Survey ABT1 will include one plasma specimen for anti-a titer with one corresponding titer cell (3% red blood cell suspension). Each shipment of Survey ABT2 will include one plasma specimen for anti-d titer, with one corresponding titer cell (3% red blood cell suspension). 162 Transfusion Medicine College of American Pathologists

www.cap.org Transfusion-Transmitted Viruses Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). The CAP and AABB provide jointly sponsored proficiency testing programs for laboratories involved in testing donor blood and diagnostic clinical patient samples for serologic markers of hepatitis and other transfusion-related diseases, as well as for parentage testing. These programs include Viral Marker Series 1, Series 2, and Series 3 (Surveys VM1, VM2, and VM3), and the Parentage Testing Programs (PAR, PARF). For assistance in determining which Viral Marker Series is appropriate for your laboratory s needs, contact a CAP Customer Contact Center Representative at 800-323-4040 option 1. AABB/CAP Viral Markers Series 1 VM1 Analyte VM1 Challenges per Shipment Anti-HAV, IgM 5 Anti-HAV, total 5 Anti-HBc, IgM 5 Anti-HBc, total 5 Anti-HBs 5 Anti-HCV 5 Anti-HIV-1 5 Anti-HIV-1/2 5 Anti-HIV-2 5 HBsAg 5 Survey VM1 is designed for laboratories performing general viral marker testing. Reporting areas for HIV-1 and HIV-2 Western Blot testing will be provided. Each shipment will include five 3.5-mL liquid serum specimens. Note: Survey VM1 material is not compatible with rapid anti-hiv-1 or anti-hiv1/2 kits. Please enroll in Surveys RHIV, RHIVW, AHIV, or AHIVW (page 165) if using a rapid kit. Product Fulfillment Group VM Handle with Care Specimens included in this section may contain pathogens and must be handled with extreme care. These specimens must be dealt with and disposed of only by trained laboratory personnel. Treat specimens as though they are capable of transmitting hepatitis and/or other blood-borne diseases. 2008 Surveys & Anatomic Pathology Education Programs Transfusion-Transmitted Viruses 163

800-323-4040 Option 1 for Customer Contact Center AABB/CAP Viral Markers Series 2 VM2 Analyte VM2 Challenges per Shipment Anti-HBe 5 HBeAg 5 Each shipment will include five 3.5-mL liquid serum specimens. Product Fulfillment Group VM AABB/CAP Viral Markers Series 3 VM3 Analyte VM3 Challenges per Shipment Anti-CMV 3 Anti-HTLV-I/II 3 HIV-1 p24 antigen 3 Reporting areas for HTLV-I Western Blot testing will be provided. Each shipment will include three 3.5-mL liquid serum specimens. Product Fulfillment Group VM New Viral Markers Series 4 VM4 Analyte VM4 Challenges per Shipment Anti-Trypanosoma cruzi (Chagas Disease) 2 Each shipment will include two 1.0 ml specimens for the qualitative detection of antibodies to T. cruzi. Product Fulfillment Group VM 164 Transfusion-Transmitted Viruses College of American Pathologists

www.cap.org Anti-HIV-1/2 AHIV, AHIVW Analyte AHIV AHIVW Challenges per Shipment Anti-HIV-1/2 5 Anti-HIV-1/2, waived 2 Survey AHIV is designed for laboratories performing anti-hiv-1/2 testing using a rapid method. Survey AHIVW is designed for laboratories performing anti-hiv-1/2 testing using a waived method; space will be provided for reporting anti-hiv-1/2 for up to five different locations within your institution. Anti-HIV-1 RHIV, RHIVW Analyte RHIV RHIVW Challenges per Shipment Anti-HIV-1 5 Anti-HIV-1, waived 2 Survey RHIV is designed for laboratories performing anti-hiv-1 testing using a rapid method. Survey RHIVW is designed for laboratories performing anti-hiv-1 using a waived method; space is provided for reporting anti-hiv-1 results for up to five different locations within your institution. Note: Both Survey RHIV and RHIVW are compatible with the OraQuick Rapid HIV-1 Antibody Test kit by OraSure Technologies and the Uni-Gold Recombigen HIV kit by Trinity Biotech. Survey RHIV is compatible with the MedMira Reveal HIV-1 Antibody Test kit. Nucleic Acid Testing NAT Procedure NAT Challenges per Shipment Nucleic acid testing for HBV 5 Nucleic acid testing for HIV 5 Nucleic acid testing for HCV 5 Nucleic acid testing for West Nile Virus 5 Survey NAT is designed for blood donor centers currently performing HBV, HCV, WNV, and/or HIV nucleic acid testing on donor units. Results will be reported qualitatively. Each shipment will include five 6.0-mL plasma specimens. 2008 Surveys & Anatomic Pathology Education Programs Transfusion-Transmitted Viruses 165

800-323-4040 Option 1 for Customer Contact Center Parentage/Relationship Testing Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS). AABB/CAP Parentage/Relationship Testing PAR, PARF Analyte/Procedure PAR PARF Challenges per Shipment Calculation challenge 1 DNA testing (PCR) 4 Each shipment of Survey PAR will include three liquid whole blood paternity trio specimens. Survey PARF will include three blood-stained filter paper paternity trio specimens. A buccal swab will be provided for a second alleged father challenge in Surveys PAR and PARF. Participants may report results for short tandem repeats (STRs), Y-STRs, as well as the conclusions. Note: The calculation exercise is a paper challenge. 166 Parentage/Relationship Testing College of American Pathologists